Scalable Newborn Screening Solutions: Bioinformatics and Next-Generation Sequencing

Overview

Journal Int J Neonatal Screen

Date 2021 Oct 26

PMID 34698050

Citations 2

Authors

Nicole Ruiz-Schultz

Bryce Asay

Andreas Rohrwasser

Affiliations

Soon will be listed here.

Abstract

Expansion of the newborn disorder panel requires the incorporation of new testing modalities. This is especially true for disorders lacking robust biomarkers for detection in primary screening methods and for disorders requiring genotyping or sequencing as a second-tier and/or diagnostic test. In this commentary, we discuss how next-generation sequencing (NGS) methods can be used as a secondary testing method in NBS. Additionally, we elaborate on the importance of genomic variant repositories for the annotation and interpretation of variants. Barriers to the incorporation of NGS and bioinformatics within NBS are discussed, and ideas for a regional bioinformatics model and shared variant repository are presented as potential solutions.

Citing Articles

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).

Therrell B, Padilla C, Borrajo G, Khneisser I, Schielen P, Knight-Madden J Int J Neonatal Screen. 2024; 10(2).

PMID: 38920845 PMC: 11203842. DOI: 10.3390/ijns10020038.

The Editor's Choice for Issue 4, Volume 7.

Millington D Int J Neonatal Screen. 2022; 8(1).

PMID: 35323200 PMC: 8949036. DOI: 10.3390/ijns8010021.

References

Bodian D, Klein E, Iyer R, Wong W, Kothiyal P, Stauffer D . Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genet Med. 2015; 18(3):221-30. DOI: 10.1038/gim.2015.111. View

Quon B, Rowe S . New and emerging targeted therapies for cystic fibrosis. BMJ. 2016; 352:i859. PMC: 4817245. DOI: 10.1136/bmj.i859. View

Castellani C . CFTR2: How will it help care?. Paediatr Respir Rev. 2013; 14 Suppl 1:2-5. DOI: 10.1016/j.prrv.2013.01.006. View

Minter Baerg M, Stoway S, Hart J, Mott L, Peck D, Nett S . Precision newborn screening for lysosomal disorders. Genet Med. 2017; 20(8):847-854. DOI: 10.1038/gim.2017.194. View

Yang S, Lincoln S, Kobayashi Y, Nykamp K, Nussbaum R, Topper S . Sources of discordance among germ-line variant classifications in ClinVar. Genet Med. 2017; 19(10):1118-1126. PMC: 5632819. DOI: 10.1038/gim.2017.60. View

Berg J, Agrawal P, Bailey Jr D, Beggs A, Brenner S, Brower A . Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017; 139(2). PMC: 5260149. DOI: 10.1542/peds.2016-2252. View

Kemp S, Pujol A, Waterham H, van Geel B, Boehm C, Raymond G . ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat. 2001; 18(6):499-515. DOI: 10.1002/humu.1227. View

Smith L, Bainbridge M, Parad R, Bhattacharjee A . Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges. Int J Neonatal Screen. 2020; 6(2). PMC: 7189780. DOI: 10.3390/ijns6020032. View

Brunelli L, Jenkins S, Gudgeon J, Bleyl S, Miller C, Tvrdik T . Targeted gene panel sequencing for the rapid diagnosis of acutely ill infants. Mol Genet Genomic Med. 2019; 7(7):e00796. PMC: 6625092. DOI: 10.1002/mgg3.796. View

10.

Duffner P, Jalal K, Carter R . The Hunter's Hope Krabbe family database. Pediatr Neurol. 2008; 40(1):13-8. DOI: 10.1016/j.pediatrneurol.2008.08.011. View

11.

Bhattacharjee A, Sokolsky T, Wyman S, Reese M, Puffenberger E, Strauss K . Development of DNA confirmatory and high-risk diagnostic testing for newborns using targeted next-generation DNA sequencing. Genet Med. 2014; 17(5):337-47. DOI: 10.1038/gim.2014.117. View

12.

Henrie A, Hemphill S, Ruiz-Schultz N, Cushman B, DiStefano M, Azzariti D . ClinVar Miner: Demonstrating utility of a Web-based tool for viewing and filtering ClinVar data. Hum Mutat. 2018; 39(8):1051-1060. PMC: 6043391. DOI: 10.1002/humu.23555. View

13.

Deignan J, Astbury C, Cutting G, Del Gaudio D, Gregg A, Grody W . CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020; 22(8):1288-1295. PMC: 8268680. DOI: 10.1038/s41436-020-0822-5. View

14.

Holm I, Agrawal P, Ceyhan-Birsoy O, Christensen K, Fayer S, Frankel L . The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018; 18(1):225. PMC: 6038274. DOI: 10.1186/s12887-018-1200-1. View

15.

Hong X, Daiker J, Sadilek M, Ruiz-Schultz N, Kumar A, Norcross S . Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots. Genet Med. 2020; 23(3):555-561. PMC: 10395749. DOI: 10.1038/s41436-020-01017-5. View

16.

Clark M, Hildreth A, Batalov S, Ding Y, Chowdhury S, Watkins K . Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Sci Transl Med. 2019; 11(489). PMC: 9512059. DOI: 10.1126/scitranslmed.aat6177. View

17.

Baker M, Atkins A, Cordovado S, Hendrix M, Earley M, Farrell P . Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study. Genet Med. 2015; 18(3):231-8. PMC: 4802962. DOI: 10.1038/gim.2014.209. View

18.

Boemer F, Fasquelle C, dOtreppe S, Josse C, Dideberg V, Segers K . A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases. Sci Rep. 2017; 7(1):17641. PMC: 5732277. DOI: 10.1038/s41598-017-18038-x. View

19.

Loeber J, Platis D, Zetterstrom R, Almashanu S, Boemer F, Bonham J . Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010. Int J Neonatal Screen. 2021; 7(1). PMC: 8006225. DOI: 10.3390/ijns7010015. View

20.

Ruiz-Schultz N, Sant D, Norcross S, Dansithong W, Hart K, Asay B . Methods and feasibility study for exome sequencing as a universal second-tier test in newborn screening. Genet Med. 2021; 23(4):767-776. DOI: 10.1038/s41436-020-01058-w. View